- French health authorities restore exeptional reimbursement of trabectedin (Yondelis®) for patients with advanced soft tissue sarcomas
- BAYER’S REGORAFENIB (STIVARGA®) APPROVED FOR THE TREATMENT OF GIST-PATIENTS IN JAPAN
- Bayer's regorafenib (STIVARGA®) approved for the treatment of GIST patients in Japan
- U.S.A.: INITIATION OF PHASE II TRIAL OF PONATINIB IN PATIENTS WITH GIST
- USA: Initiation of phase II trial of Ponatinib in patients with GIST
- 18.02.2014 - 19.02.2014 ESMO GIST & Sarcom...
Our visitors are from ...
130062 visits from 150 countries
|7%||Russian Federation (9641)|